Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications
A Phase 1 Study Evaluating the Pharmacokinetics and Safety of Avacopan in Participants with End-Stage Kidney Disease on Hemodialysis.
Journal: Journal of clinical pharmacology
Published: December 23, 2025
Pharmacokinetics and Safety of a Single Dose of Brensocatib in Participants with Hepatic Impairment and Matched Participants with Normal Hepatic Functions.
Journal: Clinical pharmacokinetics
Published: May 28, 2025
Pharmacokinetics and Safety of Fezolinetant in Women with Hepatic or Renal Impairment.
Journal: Journal of clinical pharmacology
Published: April 04, 2025
Pharmacokinetics and Safety of Navitoclax in Hepatic Impairment.
Journal: Clinical pharmacokinetics
Published: January 27, 2025
Effect of Mild to Moderate Hepatic Impairment on Valemetostat Pharmacokinetics: An Open-Label, Phase I Study.
Journal: Clinical pharmacology in drug development
Published: January 17, 2025
Pharmacokinetics, safety, and tolerability of fedratinib in adults with moderate and severe hepatic impairment: results from the phase 1 FEDR-CP-001 trial.
Journal: Cancer chemotherapy and pharmacology
Published: January 02, 2025
Effects of Hepatic or Renal Impairment on Pharmacokinetics of Fruquintinib.
Journal: Journal of clinical pharmacology
Published: December 20, 2024
Physiologically-Based Pharmacokinetic Modeling of Trofinetide in Moderate Renal Impairment for Phase 1 Clinical Study Dose Selection with Model Validation.
Journal: European journal of drug metabolism and pharmacokinetics
Published: October 16, 2024
The pharmacokinetics of brensocatib in participants with renal impairment following a single oral administration.
Journal: British journal of clinical pharmacology
Published: July 08, 2024
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects.
Journal: Pharmacotherapy
Published: January 31, 2024
Impact of renal impairment on the pharmacokinetic profile of intravenous difelikefalin, a kappa opioid receptor agonist for the treatment of pruritus.
Journal: BMC nephrology
Published: January 25, 2024
Effect of Hepatic Impairment on Trilaciclib Pharmacokinetics.
Journal: Journal of clinical pharmacology
Published: December 18, 2023
Last Updated: 09/26/2026